150 related articles for article (PubMed ID: 16763612)
21. Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases.
Boiocchi L; Witter RE; He B; Subramaniyam S; Mathew S; Nie K; Cerutti A; Coleman M; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2012 Apr; 137(4):647-59. PubMed ID: 22431543
[TBL] [Abstract][Full Text] [Related]
22. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions.
Falleni M; Pellegrini C; Marchetti A; Roncalli M; Nosotti M; Palleschi A; Santambrogio L; Coggi G; Bosari S
Lung Cancer; 2005 May; 48(2):211-6. PubMed ID: 15829320
[TBL] [Abstract][Full Text] [Related]
23. MCL-1 promoter insertions dial-up aggressiveness of chronic leukemia.
Kitada S; Reed JC
J Natl Cancer Inst; 2004 May; 96(9):642-3. PubMed ID: 15126592
[No Abstract] [Full Text] [Related]
24. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
Filip AA; Ciseł B; Wąsik-Szczepanek E
Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
[TBL] [Abstract][Full Text] [Related]
25. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
26. TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.
Pérez-Chacón G; Llobet D; Pardo C; Pindado J; Choi Y; Reed JC; Zapata JM
J Immunol; 2012 Jul; 189(2):1053-61. PubMed ID: 22711886
[TBL] [Abstract][Full Text] [Related]
27. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival.
Ghia P; Boussiotis VA; Schultze JL; Cardoso AA; Dorfman DM; Gribben JG; Freedman AS; Nadler LM
Blood; 1998 Jan; 91(1):244-51. PubMed ID: 9414291
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Chlorambucil and Valproic Acid on Cell Viability, Apoptosis and Expression of
Lipska K; Filip A; Gumieniczek A
Cells; 2021 May; 10(5):. PubMed ID: 34063233
[TBL] [Abstract][Full Text] [Related]
29. Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma.
Schmechel SC; LeVasseur RJ; Yang KH; Koehler KM; Kussick SJ; Sabath DE
Leukemia; 2004 Apr; 18(4):841-55. PubMed ID: 14961037
[TBL] [Abstract][Full Text] [Related]
30. Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
de Frias M; Iglesias-Serret D; Cosialls AM; Coll-Mulet L; Santidrián AF; González-Gironès DM; de la Banda E; Pons G; Gil J
Haematologica; 2009 Dec; 94(12):1698-707. PubMed ID: 19815839
[TBL] [Abstract][Full Text] [Related]
31. Richter syndrome with follicular colonization of chronic lymphocytic leukemia/small lymphocytic lymphoma cells mimicking follicular lymphoma.
Tabata R; Tabata C; Nagai T; Yasumizu R; Kojima M
Int J Surg Pathol; 2014 Dec; 22(8):736-43. PubMed ID: 24249845
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
33. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
[TBL] [Abstract][Full Text] [Related]
34. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
Mackus WJ; Kater AP; Grummels A; Evers LM; Hooijbrink B; Kramer MH; Castro JE; Kipps TJ; van Lier RA; van Oers MH; Eldering E
Leukemia; 2005 Mar; 19(3):427-34. PubMed ID: 15674362
[TBL] [Abstract][Full Text] [Related]
36. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
Yu W; Denu RA; Krautkramer KA; Grindle KM; Yang DT; Asimakopoulos F; Hematti P; Denu JM
J Biol Chem; 2016 Feb; 291(7):3268-79. PubMed ID: 26631723
[TBL] [Abstract][Full Text] [Related]
37. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia.
Trentin L; Zambello R; Agostini C; Enthammer C; Cerutti A; Adami F; Zamboni S; Semenzato G
Blood; 1994 Dec; 84(12):4249-56. PubMed ID: 7994039
[TBL] [Abstract][Full Text] [Related]
38. Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.
Hoeller S; Bihl MP; Zihler D; Cogliatti S; Ponzoni M; Zettl A; Went P; Foerster A; Hirschmann P; Tzankov A; Dirnhofer S
Hum Pathol; 2012 Mar; 43(3):405-12. PubMed ID: 21855110
[TBL] [Abstract][Full Text] [Related]
39. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis and the pathogenesis of lymphoma.
Voutsadakis IA
Acta Oncol; 2000; 39(2):151-6. PubMed ID: 10859004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
